Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2019 Earnings Conference Call March 3, 2020 4:30 PM ET Company Participants Paul Cox - Head of Investor Relations Andre Turenne - President & Chief Executive Officer Omar Khwaja - Chief Medical Officer & Head of R&D Allison Dorval - Chief Financial Officer Conference Call Participants Laura Chico - Wedbush Charles Duncan - Cantor Fitzgerald Aaron Welch - H. C. Wainwright Hannah Latimer - Morgan Stanley Yanan Zhu - Wells Fargo Silvan Tuerkcan - Oppenheimer Operator ...

Voyager Therapeutics, Inc (NASDAQ:VYGR) Q3 2019 Results Conference Call November 6, 2019 8:00 AM ET Company Participants Vasilis Kariolis - Assistant Controller Andre Turenne - President and Chief Executive Officer Omar Khwaja - Chief Medical Officer and Head of R&D Matt Ottmer - Chief Operating Officer Conference Call Participants Phil Nadeau - Cowen and Company Charles Duncan - Cantor Fitzgerald Dane Leone - Raymond James Jim Birchenough - Wells Fargo Jeff Hung - Morgan Stanley Laura Chico - Wedbush Secur ...

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q2 2019 Earnings Conference Call August 9, 2019 8:00 AM ET Company Participants Allison Dorval - Chief Financial Officer Andre Turenne - President and Chief Executive Officer Omar Khwaja - Chief Medical Officer and Head of Research and Development Matthew Ottmer - Chief Operating Officer Conference Call Participants Dane Leone - Raymond James Phil Nadeau - Cowen and Company Aron Welch - H.C. Wainwright Tom Schrader - BTIG Christopher Marai - Nomura Jeff Hung - Morgan ...

® Corporate Presentation August 2019 Forward-Looking Statements This presentation contains forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 and other federal securities laws. The use of words such as "may," "might," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "undoubtedly," "project," "intend," "future," "potential," or "continue," and other similar expressions are intended to identify forward-lo ...

® Corporate Presentation May 2019 Forward-Looking Statements This presentation contains forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 and other federal securities laws. The use of words such as "may," "might," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "undoubtedly," "project," "intend," "future," "potential," or "continue," and other similar expressions are intended to identify forward-looki ...

® Corporate Presentation February 2019 Forward-Looking Statements This presentation contains forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 and other federal securities laws. The use of words such as "may," "might," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "undoubtedly," "project," "intend," "future," "potential," or "continue," and other similar expressions are intended to identify forward- ...

Voyager Therapeutics (NASDAQ:VYGR) Q4 2018 Results Earnings Conference Call February 26, 2019 4:30 PM ET Company Participants Matt Osborne - Vice President-Corporate Affairs, Communications and Investor Relations Andre Turenne - President and Chief Executive Officer Allison Dorval - Chief Financial Officer Conference Call Participants Dane Leone - Raymond James Jackson Harvey - Nomura Laura Christianson - Cowen Jeff Hung - Morgan Stanley Operator Good afternoon, and welcome to the Voyager Therapeutics' Four ...